Fri, May 11, 2012
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012

Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. che-bank-37th-annual-health-care-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care... -- SAN DIEGO, May 4, 2012 /PRNewswire/ --

Neurocrine Biosciences To Present At The Deutsche Bank 37th Annual Health Care Conference

[ ]

Live Audio Webcast Wednesday, May 9, 2012

SAN DIEGO, May 4, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Deutsche Bank 37th Annual Health Care Conference in Boston.   

The live presentation takes place on Wednesday, May 9 at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at [ http://www.neurocrine.com ].

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].

 

SOURCE Neurocrine Biosciences, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.neurocrine.com ]


Publication Contributing Sources